|
Originally published In Press as doi:10.1074/jbc.M204658200 on June 12, 2002
J. Biol. Chem., Vol. 277, Issue 35, 32078-32085, August 30, 2002
Nuclear Translocation of Insulin Receptor Substrate-1
by the Simian Virus 40 T Antigen and the Activated Type 1 Insulin-like
Growth Factor Receptor*
Marco
Prisco,
Francesca
Santini,
Raffaele
Baffa,
Mingli
Liu,
Robert
Drakas,
An
Wu, and
Renato
Baserga
From the Kimmel Cancer Center, Thomas Jefferson University,
Philadelphia, Pennsylvania 19107
32D cells are a murine hemopoietic cell line that
undergoes apoptosis upon withdrawal of interleukin-3 (IL-3) from the
medium. 32D cells have low levels of the type 1 insulin-like growth
factor (IGF-I) receptor and do not express insulin receptor substrate-1 (IRS-1) or IRS-2. Ectopic expression of IRS-1 delays apoptosis but
cannot rescue 32D cells from IL-3 dependence. In 32D/IRS-1 cells, IRS-1
is detectable, as expected, in the cytosol/membrane compartment. The
SV40 large T antigen is a nuclear protein that, by itself, also fails
to protect 32D cells from apoptosis. Co-expression of IRS-1 with the
SV40 T antigen in 32D cells results in nuclear translocation of IRS-1
and survival after IL-3 withdrawal. Expression of a human IGF-I
receptor in 32D/IRS-1 cells also results in nuclear translocation of
IRS-1 and IL-3 independence. The phosphotyrosine-binding domain,
but not the pleckstrin domain, is necessary for IRS-1 nuclear
translocation. Nuclear translocation of IRS-1 was confirmed in mouse
embryo fibroblasts. These results suggest possible new roles for
nuclear IRS-1 in IGF-I-mediated growth and anti-apoptotic signaling.
*
This work was supported by Grants CA089640 and AG20956 from
the National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Kimmel Cancer Center,
Thomas Jefferson University, 233 S. 10th St., 624 BLSB,
Philadelphia, PA 19107. Tel.: 215-503-4507; Fax: 215-923-0249;
E-mail: R_baserga@lac.jci.tju.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Jo, Y. Jia, K. K. Subramanian, H. Hattori, and H. R. Luo
Cancer Cell-Derived Clusterin Modulates the Phosphatidylinositol 3'-Kinase-Akt Pathway through Attenuation of Insulin-Like Growth Factor 1 during Serum Deprivation
Mol. Cell. Biol.,
July 1, 2008;
28(13):
4285 - 4299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yu and J. C. Alwine
Interaction between Simian Virus 40 Large T Antigen and Insulin Receptor Substrate 1 Is Disrupted by the K1 Mutation, Resulting in the Loss of Large T Antigen-Mediated Phosphorylation of Akt
J. Virol.,
May 1, 2008;
82(9):
4521 - 4526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sisci, C. Morelli, C. Garofalo, F. Romeo, L. Morabito, F. Casaburi, E. Middea, S. Cascio, E. Brunelli, S. Ando, et al.
Expression of nuclear insulin receptor substrate 1 in breast cancer
J. Clin. Pathol.,
June 1, 2007;
60(6):
633 - 641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Dalmizrak, A. Wu, J. Chen, H. Sun, F. E. Utama, D. Zambelli, T. H. Tran, H. Rui, and R. Baserga
Insulin Receptor Substrate-1 Regulates the Transformed Phenotype of BT-20 Human Mammary Cancer Cells
Cancer Res.,
March 1, 2007;
67(5):
2124 - 2130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sun, X. Tu, and R. Baserga
A Mechanism for Cell Size Regulation by the Insulin and Insulin-Like Growth Factor-I Receptors
Cancer Res.,
December 1, 2006;
66(23):
11106 - 11109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chen, A. Wu, H. Sun, R. Drakas, C. Garofalo, S. Cascio, E. Surmacz, and R. Baserga
Functional Significance of Type 1 Insulin-like Growth Factor-mediated Nuclear Translocation of the Insulin Receptor Substrate-1 and {beta}-Catenin
J. Biol. Chem.,
August 19, 2005;
280(33):
29912 - 29920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Koda, M Sulkowska, L Kanczuga-Koda, and S Sulkowski
Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases
J. Clin. Pathol.,
June 1, 2005;
58(6):
645 - 649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wu, X. Tu, M. Prisco, and R. Baserga
Regulation of Upstream Binding Factor 1 Activity by Insulin-like Growth Factor I Receptor Signaling
J. Biol. Chem.,
January 28, 2005;
280(4):
2863 - 2872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sun and R. Baserga
Deletion of the Pleckstrin and Phosphotyrosine Binding Domains of Insulin Receptor Substrate-2 Does Not Impair Its Ability to Regulate Cell Proliferation in Myeloid Cells
Endocrinology,
November 1, 2004;
145(11):
5332 - 5343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Prisco, A. Maiorana, C. Guerzoni, G. Calin, B. Calabretta, R. Voit, I. Grummt, and R. Baserga
Role of Pescadillo and Upstream Binding Factor in the Proliferation and Differentiation of Murine Myeloid Cells
Mol. Cell. Biol.,
June 15, 2004;
24(12):
5421 - 5433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Sciacca, M. Prisco, A. Wu, A. Belfiore, R. Vigneri, and R. Baserga
Signaling Differences from the A and B Isoforms of the Insulin Receptor (IR) in 32D Cells in the Presence or Absence of IR Substrate-1
Endocrinology,
June 1, 2003;
144(6):
2650 - 2658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Lee, P. Zhang, M. Ivanova, S. Bonnette, S. Oesterreich, J. M. Rosen, S. Grimm, R. C. Hovey, B. K. Vonderhaar, C. R. Kahn, et al.
Developmental and Hormonal Signals Dramatically Alter the Localization and Abundance of Insulin Receptor Substrate Proteins in the Mammary Gland
Endocrinology,
June 1, 2003;
144(6):
2683 - 2694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sun, X. Tu, M. Prisco, A. Wu, I. Casiburi, and R. Baserga
Insulin-Like Growth Factor I Receptor Signaling and Nuclear Translocation of Insulin Receptor Substrates 1 and 2
Mol. Endocrinol.,
March 1, 2003;
17(3):
472 - 486.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|